As per 'Pharma Vision 2020', the Government of India aims to make India a global leader in end-to-end drug manufacturing.

The Indian pharmaceutical sector accounts for about 1.4 per cent of the global pharmaceutical industry in value terms and 10 per cent in volume terms. India ranks fourth in terms of the total pharma market share in the Asia Pacific. The Indian pharma market size is expected to grow to US$ 85 billion by 2020.

Pharmaceutical exports from India have grown at a CAGR of 21 per cent over the last decade. Higher spending on R&D, owing to products patents have made India a major destination for generic drug manufacturing.

With 70 per cent of India's population residing in rural markets, various pharma companies are investing in the distribution network in rural areas.

The projected human resource requirement in the Indian pharma sector is estimated to be about 21,50,000 by 2020

Due to a genetically diverse population and availability of skilled doctors, India has the potential to attract huge investments to its clinical trial market.

Going forward, better growth in domestic sales will depend on the ability of companies to align their product portfolio towards chronic therapies for diseases such as such as cardiovascular, anti-diabetes, anti-depressants and anti-cancers are on the rise.

PHARMA Practice at TASK

---

At TASK we have extensive knowledge and experience of working with the leading Pharmaceutical & Biotechnology companies. Therefore, we have in depth understanding of the industry and can very well measure the requirements of the client companies. PHARMA Practice grew National, focusing on Life Sciences, Data Management, Clinical Research, Core Pharma and Biotechnology.

PHARMA Basket

---

• Core Pharma - Bulk Drugs / Formulations
• Contract Research Organisations
• Biotechnology & Life Sciences
• Data Management & KPO
• Medical Equipment & Diagnostics